World's Best Scientists 2026 revealed!
Caner Süsal

Caner Süsal

Award Badge
Immunology
Turkey
2026

D-Index & Metrics

Immunology

D-Index
47
Citations
8299
World Ranking
4530
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Immunology in Turkey Leader Award
  • 2025 - Research.com Immunology in Turkey Leader Award

Overview

Caner Süsal is affiliated with Koç University in Turkey and has contributed extensively to research in medicine, with a particular focus on transplantation and related fields. Their work spans multiple subfields such as transplantation, surgery, infectious diseases, immunology, and epidemiology.

The researcher's publication record includes many articles in well-known academic journals. Frequent venues for their work include:

  • Frontiers in Immunology
  • Transplantation
  • Journal of the American Society of Nephrology
  • Transplant International
  • Pediatric Nephrology

Their studies often address major topics within transplantation and immunology. Key topics of focus are:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • SARS-CoV-2 and COVID-19 Research
  • Transplantation: Methods and Outcomes
  • Organ Donation and Transplantation
  • Cytomegalovirus and herpesvirus research
  • Immune Cell Function and Interaction

Caner Süsal has collaborated frequently with several co-authors, including:

  • Christian Morath
  • Claudius Speer
  • Christian Nußhag
  • Florian Kälble
  • Bernd Döhler

Recent published papers demonstrate the range of their research interests and contributions. Selected papers include:

  • Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2, 2021, Clinical Journal of the American Society of Nephrology
  • Bias by censoring for competing events in survival analysis, 2022, BMJ
  • Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers, 2021, Vaccines
  • The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications-Who Is at Risk? A Collaborative Transplant Study Report, 2020, Frontiers in Immunology
  • Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients, 2022, American Journal of Transplantation

The researcher's work reflects a strong involvement in the study of transplant outcomes, immunological responses, and the impact of infectious diseases in immunocompromised populations. This aligns with their broader focus on transplantation methods, outcomes, and post-transplant care.

Best Publications

  • Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

    Brian D. Tait;Caner Süsal;Howard M. Gebel;Peter W. Nickerson

  • Antibodies against MICA Antigens and Kidney-Transplant Rejection

    Yizhou Zou;Peter Stastny;Caner Süsal;Bernd Döhler

  • Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015

    Maarten Coemans;Caner Süsal;Bernd Döhler;Dany Anglicheau

  • Kidney graft failure and presensitization against HLA class I and class II antigens.

    Caner Süsal;Gerhard Opelz

  • Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.

    Gerhard Opelz;Christian Morath;Caner Süsal;Thuong Hien Tran

  • Identification of Highly Responsive Kidney Transplant Recipients Using Pretransplant Soluble CD30

    Caner Süsal;Steffen Pelzl;Bernd Döhler;Gerhard Opelz

  • No Association of Kidney Graft Loss With Human Leukocyte Antigen Antibodies Detected Exclusively by Sensitive Luminex Single-Antigen Testing: A Collaborative Transplant Study Report

    Caner Süsal;Jörg Ovens;Khaled Mahmoud;Bernd Döhler

  • Current role of human leukocyte antigen matching in kidney transplantation.

    Caner Süsal;Gerhard Opelz

  • Soluble CD30 as a predictor of kidney graft outcome.

    Steffen Pelzl;Gerhard Opelz;Manfred Wiesel;Peter Schnülle

  • Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients.

    Tania Simon;Gerhard Opelz;Manfred Wiesel;Ralf C. Ott

  • Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.

    Heiko Billing;Susanne Rieger;Jörg Ovens;Caner Süsal

  • Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis

    Antoine Bouquegneau;Antoine Bouquegneau;Charlotte Loheac;Olivier Aubert;Olivier Aubert;Yassine Bouatou;Yassine Bouatou

  • Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection1

    Steffen Pelzl;Gerhard Opelz;Volker Daniel;Manfred Wiesel

  • Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.

    Caner Süsal;Bernd Döhler;Gerhard Opelz

  • The collaborative transplant study registry.

    Gerhard Opelz;Bernd Döhler;Andrea Ruhenstroth;Sofia Cinca

  • Epidemiology and Morbidity of Epstein-Barr Virus Infection in Pediatric Renal Transplant Recipients: A Multicenter, Prospective Study

    Britta Höcker;Helmut Fickenscher;Henri Jacques Delecluse;Stephan Böhm

  • ABO-Incompatible Kidney Transplantation.

    Christian Morath;Martin Zeier;Bernd Döhler;Gerhard Opelz

  • Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.

    Caner Süsal;Daniel Wettstein;Bernd Döhler;Christian Morath

  • Influence of test technique on sensitization status of patients on the kidney transplant waiting list.

    P. Gombos;G. Opelz;S. Scherer;C. Morath

  • IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up.

    Heiko Billing;Susanne Rieger;Caner Süsal;Rüdiger Waldherr

  • Split liver transplantation: Current developments

    Christina Hackl;Katharina M Schmidt;Caner Süsal;Bernd Döhler

  • Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.

    Claudius Speer;Daniel Göth;Louise Benning;Mirabel Buylaert

  • Post‐Transplant sCD30 and Neopterin as Predictors of Chronic Allograft Nephropathy: Impact of Different Immunosuppressive Regimens

    R. Weimer;C. Süsal;S. Yildiz;A. Staak

Frequent Co-Authors

Gerhard Opelz
Gerhard Opelz Heidelberg University
Martin Zeier
Martin Zeier University Hospital Heidelberg
Volker Daniel
Volker Daniel University Hospital Heidelberg
Paul Schnitzler
Paul Schnitzler University Hospital Heidelberg
Christophe Legendre
Christophe Legendre Necker-Enfants Malades Hospital
Carsten Müller-Tidow
Carsten Müller-Tidow University Hospital Heidelberg
Michael Kirschfink
Michael Kirschfink Heidelberg University
Adriana Zeevi
Adriana Zeevi University of Pittsburgh
Elaine F. Reed
Elaine F. Reed University of California, Los Angeles
Arend Mulder
Arend Mulder Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in immunology in the USA opens doors to a variety of healthcare careers, many of which can be complemented by specialized nursing programs. For those looking to advance clinical expertise quickly, accelerated NP programs offer a fast-track way to become nurse practitioners, blending rigorous coursework with practical skills.

Non-nurses interested in entering the nursing field may find online ADN programs for non nurses particularly accessible, providing foundational training that integrates well with immunology-focused studies. Additionally, accelerated BSN programs for non nurses allow quick progression from basic healthcare roles into professional nursing positions, critical in areas involving immunology research and patient care.

For nurses aiming to specialize further, acnp programs provide advanced training in acute care settings, reinforcing a comprehensive understanding of immune responses in critical care patients. These pathways help blend immunology knowledge with clinical expertise, enhancing career prospects in both research and healthcare delivery.

Best Scientists Citing Caner Süsal

Trending Scientists